Article thumbnail

SENP1 participates in the dynamic regulation of Elk-1 SUMOylation

By James Witty, Elisa Aguilar-Martinez and Andrew D. Sharrocks


The modification of proteins with SUMO (small ubiquitin-related modifier) plays an important role in determining their functional properties. Importantly though, SUMOylation is a highly dynamic process enabling transient responses to be elicited. This dynamism is controlled by two competing conjugating and deconjugating activities. The latter activity is mediated by the SENP [SUMO1/sentrin/SMT3 (suppressor of mif two 3 homologue 1)-specific peptidase] family of SUMO-specific proteases. The transcription factor Elk-1 [ETS (E twenty-six)-like 1] undergoes rapid de-SUMOylation following cellular stimulation with growth factors, and this contributes to its conversion from a SUMO-dependent repressor into a potent transcriptional activator. In the present study we demonstrate an important role for SENP1 in the de-SUMOylation of Elk-1, and therefore an integral role in determining the Elk-1-dependent transcriptional programme. Among the SENPs, Elk-1 preferentially forms a complex with SENP1. This preferential binding is reflected by the higher efficiency of SENP1 in promoting Elk-1 transactivation. Moreover, depletion of SENP1 causes a reciprocal effect and reduces the transactivation properties of Elk-1. Partial redundancy of function with SENP2 is revealed by combinatorial knockdown studies. Importantly, depletion of SENP1 also reduces the activation of the Elk-1 target gene c-FOS. Taken together, these results therefore reveal an important role for SENP1 in the regulation of Elk-1-mediated gene expression in response to mitogenic signalling cues

Topics: Research Article
Publisher: Portland Press Ltd.
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). A recurrent phospho-sumoyl switch in transcriptional repression and beyond.
  2. (2007). A role for SUMO modification in transcriptional repression and activation.
  3. (1997). Activation of the transcriptionfactorMEF2CbytheMAPkinasep38ininflammation.Nature386,296–299
  4. (2006). Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3.
  5. (2007). Concepts in sumoylation: a decade on.
  6. (2009). Emerging roles of desumoylating enzymes.
  7. (2004). Functional transplantation of the sumoylation machinery into Escherichia coli. Protein Expr.
  8. (2007). Modification in reverse: the SUMO proteases.
  9. (2003). Phosphorylation of serine 303 is a prerequisite for the stress-inducible SUMO modification of heat shock factor 1.
  10. (2009). PIAS proteins: pleiotropic interactors associated with SUMO. Cell Mol.
  11. (2006). PIASxα differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.
  12. (2001). Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.
  13. (2009). Preparation of SUMO proteases and kinetic analysis using endogenous substrates.
  14. (2008). Regulation of the sumoylation system in gene expression.
  15. (2008). RNF is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
  16. (2004). SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1.
  17. (2009). SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.
  18. (2007). Signalling pathways and the regulation of SUMO modification.
  19. (2009). SUMO association with repressor complexes, emerging routes for transcriptional control.
  20. (2004). SUMO promotes HDAC-mediated transcriptional repression.
  21. (2002). SUMO-1 protease-1 regulates gene transcription through PML.
  22. (2007). SUMO-specific protease 1 is essential for stabilization of HIF1α during hypoxia.
  23. (2007). SUMO: getting it on.
  24. (1998). The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif.
  25. (2008). The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.